Craig A. Wheeler

Biography

 Mr. Wheeler joined Momenta as CEO in September of 2006. He drove the organization through the dispatch of its first complex medication items, including the principal bland renditions of LOVENOX® and once-day by day COPAXONE®. He has directed the organization's development into the broadened business it is today. In 2011, he was an E&Y Entrepreneur of the Year Regional Award champ. In May 2012, the Boston Globe named Momenta the main organization in their yearly Globe 100 overview of best performing organizations. Preceding joining Momenta, Mr. Wheeler was President of Chiron BioPharmaceuticals where amid his five-year residency the pharmaceutical division's worldwide deals dramatically increased. Prior to that, he was a senior individual from The Boston Consulting Group's social insurance hone and worked broadly in the medicinal services part. He started his profession at Merck's MSDRL examine unit. Mr. Wheeler is at present an individual from the Board of Directors of Amicus Therapeutics and in addition the Association for Accessible Medicines (AAM) where he already filled in as Chairman from 2014 to February 2016.

Research Interest

Cardiovascular and Metabolism, Pain, Neuroscience, Regenerative Medicine and Rare Diseases